PortViewPortView
Psychemedics logo

Psychemedics (PMD) Stock Analysis

NASDAQHealthcareMedical - Diagnostics & Research

$2.67+100.00%
1-year price historyRange $1.64 – $3.21
52-week range$2.67
$2.60$2.67

What Psychemedics does

Established in 1986 and based in Acton, Massachusetts, Psychemedics Corporation specializes in providing comprehensive drug abuse detection services. The company operates across the United States, Brazil, and various international locations, employing hair sample analysis to identify a broad spectrum of substances. Their rigorous testing methodology involves both initial screening and confirmatory analysis through mass spectrometry, adhering to recognized industry standards. Psychemedics' analytical capabilities cover a wide array of drugs, including common illicit substances like cocaine, marijuana, and PCP. They also detect various amphetamines, such as ecstasy, eve, and Adderall, along with a comprehensive list of opiates, including heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine. Furthermore, their tests identify synthetic cannabinoids (e.g., K2, Spice, Blaze), benzodiazepines (like Xanax, Valium, and Ativan), nicotine, and Fentanyl. The results of their analyses offer more than just a positive or negative finding; they provide quantitative data indicating the approximate amount of drug consumed. Crucially, the tests also yield historical information that can reveal an individual's drug use patterns over an extended period. Psychemedics serves a diverse clientele, including employers seeking applicant and employee drug screening, treatment professionals, law enforcement agencies, school administrators, and parents concerned about potential substance use by their children.

Key metrics

Market cap
$15.56M
P/E (TTM)
-5.24
EPS (TTM)
$-0.51
Beta
0.67
Dividend yield
0.00%
Revenue / share
$3.36
50-day avg
$2.10
200-day avg
$2.23
52-week high
$2.67
52-week low
$2.60
CEO
Brian Hullinger

ETFs linked to PMD

Broad-market and Healthcare sector ETFs an investor holding Psychemedics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PMD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PMD in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Psychemedics?
Psychemedics trades under the ticker PMD on NASDAQ.
Which exchange is PMD listed on?
PMD is listed on NASDAQ.
What sector does Psychemedics operate in?
Psychemedics is classified in the Healthcare sector (Medical - Diagnostics & Research industry).
How can PortView help analyze PMD in a portfolio?
PortView shows PMD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.